|
1
|
Gottlieb DJ and Punjabi NM: Diagnosis and
Management of Obstructive Sleep Apnea: A review. JAMA.
323:1389–1400. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Benjafield AV, Ayas NT, Eastwood PR,
Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin
JL, et al: Estimation of the global prevalence and burden of
obstructive sleep apnoea: A literature-based analysis. Lancet
Respir Med. 7:687–698. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mohamadian M, Chiti H, Shoghli A, Biglari
S, Parsamanesh N and Esmaeilzadeh A: COVID-19: Virology, biology
and novel laboratory diagnosis. J Gene Med.
23(e3303)2021.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Franklin KA and Lindberg E: Obstructive
sleep apnea is a common disorder in the population-a review on the
epidemiology of sleep apnea. J Thorac Dis. 7:1311–1322.
2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gu X, Zhang J, Shi Y, Shen H, Li Y, Chen Y
and Liang L: ESM1/HIF-1α pathway modulates chronic intermittent
hypoxia-induced non-small-cell lung cancer proliferation, stemness
and epithelial-mesenchymal transition. Oncol Rep. 45:1226–1234.
2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hirsch Allen AJ, Kendzerska T, Bhatti P,
Jen R, Myers R, Hajipour M, van Eeden SF and Ayas N: Obstructive
sleep apnea severity, circulating biomarkers, and cancer risk. J
Clin Sleep Med. 20:1415–1422. 2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ni W, Niu Y, Cao S, Fan C, Fan J, Zhu L
and Wang X: Intermittent hypoxia exacerbates anxiety in high-fat
diet-induced diabetic mice by inhibiting TREM2-regulated IFNAR1
signaling. J Neuroinflammation. 21(166)2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yang M, Cai W, Lin Z, Tuohuti A and Chen
X: Intermittent Hypoxia Promotes TAM-Induced Glycolysis in
Laryngeal Cancer Cells via Regulation of HK1 Expression through
Activation of ZBTB10. Int J Mol Sci. 24(14808)2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cheong AJY, Tan BKJ, Teo YH, Tan NKW, Yap
DWT, Sia CH, Ong TH, Leow LC, See A and Toh ST: Obstructive Sleep
Apnea and Lung Cancer: A Systematic Review and Meta-Analysis. Ann
Am Thorac Soc. 19:469–475. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tang SS, Liang CH, Liu YL, Wei W, Deng XR,
Shi XY, Wang LM, Zhang LJ and Yuan HJ: Intermittent hypoxia is
involved in gut microbial dysbiosis in type 2 diabetes mellitus and
obstructive sleep apnea-hypopnea syndrome. World J Gastroenterol.
28:2320–2333. 2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Almendros I, Martinez-Garcia MA, Farré R
and Gozal D: Obesity, sleep apnea, and cancer. Int J Obes (Lond).
44:1653–1667. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Prabhakar NR, Peng YJ and Nanduri J:
Hypoxia-inducible factors and obstructive sleep apnea. J Clin
Invest. 130:5042–5051. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Moriondo G, Soccio P, Minoves M, Scioscia
G, Tondo P, Foschino Barbaro MP, Pépin JL, Briançon-Marjollet A and
Lacedonia D: Intermittent Hypoxia Mediates Cancer Development and
Progression Through HIF-1 and miRNA Regulation. Arch Bronconeumol.
59:629–637. 2023.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
|
14
|
Wang N, Su X, Sams D, Prabhakar NR and
Nanduri J: P300/CBP Regulates HIF-1-Dependent Sympathetic
Activation and Hypertension by Intermittent Hypoxia. Am J Respir
Cell Mol Biol. 70:110–118. 2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Halpin-Veszeleiova K and Hatfield SM:
Oxygenation and A2AR blockade to eliminate
hypoxia/HIF-1α-adenosinergic immunosuppressive axis and improve
cancer immunotherapy. Curr Opin Pharmacol. 53:84–90.
2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu Z, Yan S, Wang J, Xu Y, Wang Y, Zhang
S, Xu X, Yang Q, Zeng X, Zhou Y, et al: Endothelial adenosine A2a
receptor-mediated glycolysis is essential for pathological retinal
angiogenesis. Nat Commun. 8(584)2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Belaidi E, Morand J, Gras E, Pépin JL and
Godin-Ribuot D: Targeting the ROS-HIF-1-endothelin axis as a
therapeutic approach for the treatment of obstructive sleep
apnea-related cardiovascular complications. Pharmacol Ther.
168:1–11. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Guan S, Suman S, Amann JM, Wu R, Carbone
DP, Wang J and Dikov MM: Metabolic reprogramming by adenosine
antagonism and implications in non-small cell lung cancer therapy.
Neoplasia. 32(100824)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bruzzese L, Fromonot J, By Y, Durand-Gorde
JM, Condo J, Kipson N, Guieu R, Fenouillet E and Ruf J: NF-κB
enhances hypoxia-driven T-cell immunosuppression via upregulation
of adenosine A(2A) receptors. Cell Signal. 26:1060–1067.
2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sitkovsky MV, Kjaergaard VJ, Lukashev D
and Ohta A: Hypoxia-adenosinergic immunosuppression: Tumor
protection by T regulatory cells and cancerous tissue hypoxia. Clin
Cancer Res. 14:5947–5952. 2008.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ke RH, Xiong J, Liu Y and Ye ZR: Adenosine
A2a receptor induced gliosis via Akt/NF-kappaB pathway in vitro.
Neurosci Res. 65:280–285. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Eckle T, Kewley EM, Brodsky KS, Tak E,
Bonney S, Gobel M, Anderson D, Glover LE, Riegel AK, Colgan SP and
Eltzschig HK: Identification of hypoxia-inducible factor HIF-1A as
transcriptional regulator of the A2B adenosine receptor during
acute lung injury. J Immunol. 192:1249–1256. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Steingold JM and Hatfield SM: Targeting
Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells
During Cancer Immunotherapy. Front Immunol.
11(570041)2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Castillo CA, León D, Ruiz MA, Albasanz JL
and Martín M: Modulation of adenosine A1 and A2A receptors in C6
glioma cells during hypoxia: Involvement of endogenous adenosine. J
Neurochem. 105:2315–2329. 2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Pang L, Ng KT, Liu J, Yeung WO, Zhu J,
Chiu TS, Liu H, Chen Z, Lo CM and Man K: Plasmacytoid dendritic
cells recruited by HIF-1α/eADO/ADORA1 signaling induce
immunosuppression in hepatocellular carcinoma. Cancer Lett.
522:80–92. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Orrù G, Storari M, Scano A, Piras V, Taibi
R and Viscuso D: Obstructive Sleep Apnea, oxidative stress,
inflammation and endothelial dysfunction-An overview of predictive
laboratory biomarkers. Eur Rev Med Pharmacol Sci. 24:6939–6948.
2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fang S, Sun S, Cai H, Zou X, Wang S, Hao
X, Wan X, Tian J, Li Z, He Z, et al: IRGM/Irgm1 facilitates
macrophage apoptosis through ROS generation and MAPK signal
transduction: Irgm1(+/-) mice display increases atherosclerotic
plaque stability. Theranostics. 11:9358–9375. 2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lin YF, Li MH, Huang RH, Zhang SZ, Xu XF,
Zhou HM, Liu MH, Liao XX, Liao LZ, Guo Y and Zhuang XD: GP73
enhances the ox-LDL-induced inflammatory response in THP-1 derived
macrophages via affecting NLRP3 inflammasome signaling. Int J
Cardiol. 387(131109)2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Balzan S and Lubrano V: LOX-1 receptor: A
potential link in atherosclerosis and cancer. Life Sci. 198:79–86.
2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sylvers-Davie KL and Davies BSJ:
Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and
ANGPTL8. Am J Physiol Endocrinol Metab. 321:E493–E508.
2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li W and Wang W: Causal modulation of
lipid metabolism may shape the inflammatory microenvironment and
potentially augment immunotherapy: A comprehensive genetic
landscape revealed by Mendelian randomization analysis. Int
Immunol. 36:291–302. 2024.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang
J, Yuan Q, Yu H, Xu W and Xie X: New insights into oxidative stress
and inflammation during diabetes mellitus-accelerated
atherosclerosis. Redox Biol. 20:247–260. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lara-Guzmán OJ, Gil-Izquierdo A, Medina S,
Osorio E, Álvarez-Quintero R, Zuluaga N, Oger C, Galano JM, Durand
T and Muñoz-Durango K: Oxidized LDL triggers changes in oxidative
stress and inflammatory biomarkers in human macrophages. Redox
Biol. 15:1–11. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Incalza MA, D'Oria R, Natalicchio A,
Perrini S, Laviola L and Giorgino F: Oxidative stress and reactive
oxygen species in endothelial dysfunction associated with
cardiovascular and metabolic diseases. Vascul Pharmacol. 100:1–19.
2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Xu D, Hu YH, Gou X, Li FY, Yang XY, Li YM
and Chen F: Oxidative Stress and Antioxidative Therapy in Pulmonary
Arterial Hypertension. Molecules. 27(3724)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Li M, Xin S, Gu R, Zheng L, Hu J, Zhang R
and Dong H: Novel Diagnostic Biomarkers Related to Oxidative Stress
and Macrophage Ferroptosis in Atherosclerosis. Oxid Med Cell
Longev. 2022(8917947)2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kattoor AJ, Pothineni NVK, Palagiri D and
Mehta JL: Oxidative Stress in Atherosclerosis. Curr Atheroscler
Rep. 19(42)2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Batty M, Bennett MR and Yu E: The Role of
Oxidative Stress in Atherosclerosis. Cells. 11(3843)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ranjbarvaziri S, Kooiker KB, Ellenberger
M, Fajardo G, Zhao M, Vander Roest AS, Woldeyes RA, Koyano TT, Fong
R, Ma N, et al: Altered Cardiac Energetics and Mitochondrial
Dysfunction in Hypertrophic Cardiomyopathy. Circulation.
144:1714–1731. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Tian L, Cao W, Yue R, Yuan Y, Guo X, Qin
D, Xing J and Wang X: Pretreatment with Tilianin improves
mitochondrial energy metabolism and oxidative stress in rats with
myocardial ischemia/reperfusion injury via AMPK/SIRT1/PGC-1 alpha
signaling pathway. J Pharmacol Sci. 139:352–360. 2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Dikalova AE, Pandey A, Xiao L, Arslanbaeva
L, Sidorova T, Lopez MG, Billings FT 4th, Verdin E, Auwerx J,
Harrison DG and Dikalov SI: Mitochondrial Deacetylase Sirt3 Reduces
Vascular Dysfunction and Hypertension While Sirt3 Depletion in
Essential Hypertension Is Linked to Vascular Inflammation and
Oxidative Stress. Circ Res. 126:439–452. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kent BD, Grote L, Ryan S, Pépin JL,
Bonsignore MR, Tkacova R, Saaresranta T, Verbraecken J, Lévy P,
Hedner J and McNicholas WT: Diabetes mellitus prevalence and
control in sleep-disordered breathing: The European Sleep Apnea
Cohort (ESADA) study. Chest. 146:982–990. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Giampá SQC, Lorenzi-Filho G and Drager LF:
Obstructive sleep apnea and metabolic syndrome. Obesity (Silver
Spring). 31:900–911. 2023.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Lévy P, Kohler M, McNicholas WT, Barbé F,
McEvoy RD, Somers VK, Lavie L and Pépin JL: Obstructive sleep
apnoea syndrome. Nat Rev Dis Primers. 1(15015)2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Unnikrishnan D, Jun J and Polotsky V:
Inflammation in sleep apnea: An update. Rev Endocr Metab Disord.
16:25–34. 2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Alterki A, Abu-Farha M, Al Shawaf E,
Al-Mulla F and Abubaker J: Investigating the Relationship between
Obstructive Sleep Apnoea, Inflammation and Cardio-Metabolic
Diseases. Int J Mol Sci. 24(6807)2023.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chen Z, Zeng J, Pei X, Zhao J, Zhao F,
Zhang G, Liang K, Li J and Zhao X: Causal Relationships Between
Circulating Inflammatory Proteins and Obstructive Sleep Apnea: A
Bidirectional Mendelian Randomization Study. Nat Sci Sleep.
16:787–800. 2024.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Malicki M, Karuga FF, Szmyd B, Sochal M
and Gabryelska A: Obstructive Sleep Apnea, Circadian Clock
Disruption, and Metabolic Consequences. Metabolites.
13(60)2022.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Gras E, Belaidi E, Briançon-Marjollet A,
Pépin JL, Arnaud C and Godin-Ribuot D: Endothelin-1 mediates
intermittent hypoxia-induced inflammatory vascular remodeling
through HIF-1 activation. J Appl Physiol (1985). 120:437–443.
2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Taylor CT, Kent BD, Crinion SJ, McNicholas
WT and Ryan S: Human adipocytes are highly sensitive to
intermittent hypoxia induced NF-kappaB activity and subsequent
inflammatory gene expression. Biochem Biophys Res Commun.
447:660–665. 2014.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Imamura T, Poulsen O and Haddad GG:
Intermittent hypoxia induces murine macrophage foam cell formation
by IKK-β-dependent NF-κB pathway activation. J Appl Physiol (1985).
121:670–677. 2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Lv R, Zhao Y, Wang X, He Y, Dong N, Min X,
Liu X, Yu Q, Yuan K, Yue H and Yin Q: GLP-1 analogue liraglutide
attenuates CIH-induced cognitive deficits by inhibiting oxidative
stress, neuroinflammation, and apoptosis via the Nrf2/HO-1 and
MAPK/NF-κB signaling pathways. Int Immunopharmacol.
142(113222)2024.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Murphy AM, Thomas A, Crinion SJ, Kent BD,
Tambuwala MM, Fabre A, Pepin JL, Roche HM, Arnaud C and Ryan S:
Intermittent hypoxia in obstructive sleep apnoea mediates insulin
resistance through adipose tissue inflammation. Eur Respir J.
49(1601731)2017.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Arnaud C, Poulain L, Lévy P and Dematteis
M: Inflammation contributes to the atherogenic role of intermittent
hypoxia in apolipoprotein-E knock out mice. Atherosclerosis.
219:425–431. 2011.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Huang T, Sands SA, Stampfer MJ, Tworoger
SS, Hu FB and Redline S: Insulin Resistance, Hyperglycemia, and
Risk of Developing Obstructive Sleep Apnea in Men and Women in the
United States. Ann Am Thorac Soc. 19:1740–1749. 2022.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Meng X, Wen H and Lian L: Association
between triglyceride glucose-body mass index and obstructive sleep
apnea: A study from NHANES 2015-2018. Front Nutr.
11(1424881)2024.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Barros D and García-Río F: Obstructive
sleep apnea and dyslipidemia: From animal models to clinical
evidence. Sleep. 42(zsy236)2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Tang H, Zhou Q, Zheng F, Wu T, Tang YD and
Jiang J: The Causal Effects of Lipid Profiles on Sleep Apnea. Front
Nutr. 9(910690)2022.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Sun J, Hu J, Tu C, Zhong A and Xu H:
Obstructive Sleep Apnea Susceptibility Genes in Chinese Population:
A Field Synopsis and Meta-Analysis of Genetic Association Studies.
PLoS One. 10(e0135942)2015.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Uyrum E, Balbay O, Annakkaya AN, Gulec
Balbay E, Silan F and Arbak P: The relationship between obstructive
sleep apnea syndrome and apolipoprotein E genetic variants.
Respiration. 89:195–200. 2015.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Meszaros M and Bikov A: Obstructive Sleep
Apnoea and Lipid Metabolism: The Summary of Evidence and Future
Perspectives in the Pathophysiology of OSA-Associated
Dyslipidaemia. Biomedicines. 10(2754)2022.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Burke SL, Hu T, Spadola CE, Li T, Naseh M,
Burgess A and Cadet T: Mild cognitive impairment: associations with
sleep disturbance, apolipoprotein e4, and sleep medications. Sleep
Med. 52:168–176. 2018.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Huguenard CJC, Cseresznye A, Darcey T,
Nkiliza A, Evans JE, Hazen SL, Mullan M, Crawford F and Abdullah L:
Age and APOE affect L-carnitine system metabolites in the brain in
the APOE-TR model. Front Aging Neurosci. 14(1059017)2023.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Turner AD, Locklear CE, Oruru D, Briggs
AQ, Bubu OM and Seixas A: Exploring the combined effects of sleep
apnea and APOE-e4 on biomarkers of Alzheimer's disease. Front Aging
Neurosci. 14(1017521)2023.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Kim JK, Fillmore JJ, Chen Y, Yu C, Moore
IK, Pypaert M, Lutz EP, Kako Y, Velez-Carrasco W, Goldberg IJ, et
al: Tissue-specific overexpression of lipoprotein lipase causes
tissue-specific insulin resistance. Proc Natl Acad Sci USA.
98:7522–7527. 2001.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Wang N, Shi XF, Khan SA, Wang B, Semenza
GL, Prabhakar NR and Nanduri J: Hypoxia-inducible factor-1 mediates
pancreatic β-cell dysfunction by intermittent hypoxia. Am J Physiol
Cell Physiol. 319:C922–C932. 2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Fang Y, Zhang Q, Tan J, Li L, An X and Lei
P: Intermittent hypoxia-induced rat pancreatic β-cell apoptosis and
protective effects of antioxidant intervention. Nutr Diabetes.
4(e131)2014.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Dempsey JA, Veasey SC, Morgan BJ and
O'Donnell CP: Pathophysiology of sleep apnea. Physiol Rev.
90:47–112. 2010.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Zeng S, Wang Y, Ai L, Huang L, Liu Z, He
C, Bai Q and Li Y: Chronic intermittent hypoxia-induced oxidative
stress activates TRB3 and phosphorylated JNK to mediate insulin
resistance and cell apoptosis in the pancreas. Clin Exp Pharmacol
Physiol. 51(e13843)2024.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Nascimento DC, Viacava PR, Ferreira RG,
Damaceno MA, Piñeros AR, Melo PH, Donate PB, Toller-Kawahisa JE,
Zoppi D, Veras FP, et al: Sepsis expands a CD39(+) plasmablast
population that promotes immunosuppression via adenosine-mediated
inhibition of macrophage antimicrobial activity. Immunity.
54:2024–2041.e8. 2021.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Pasquini S, Contri C, Borea PA, Vincenzi F
and Varani K: Adenosine and Inflammation: Here, There and
Everywhere. Int J Mol Sci. 22(7685)2021.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Haskó G, Linden J, Cronstein B and Pacher
P: Adenosine receptors: therapeutic aspects for inflammatory and
immune diseases. Nat Rev Drug Discov. 7:759–770. 2008.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Junqueira SC, Dos Santos Coelho I,
Lieberknecht V, Cunha MP, Calixto JB, Rodrigues ALS, Santos ARS and
Dutra RC: Inosine, an Endogenous Purine Nucleoside, Suppresses
Immune Responses and Protects Mice from Experimental Autoimmune
Encephalomyelitis: A Role for A2A Adenosine Receptor. Mol
Neurobiol. 54:3271–3285. 2017.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Impellizzeri D, Di Paola R, Esposito E,
Mazzon E, Paterniti I, Melani A, Bramanti P, Pedata F and Cuzzocrea
S: CGS 21680, an agonist of the adenosine (A2A) receptor, decreases
acute lung inflammation. Eur J Pharmacol. 668:305–316.
2011.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Lu Y, Zhu W, Zhang GX, Chen JC, Wang QL,
Mao MY, Deng SC, Jin LP, Liu H and Kuang YH: Adenosine A2A receptor
activation regulates the M1 macrophages activation to initiate
innate and adaptive immunity in psoriasis. Clin Immunol.
266(110309)2024.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Mohsenin A, Mi T, Xia Y, Kellems RE, Chen
JF and Blackburn MR: Genetic removal of the A2A adenosine receptor
enhances pulmonary inflammation, mucin production, and angiogenesis
in adenosine deaminase-deficient mice. Am J Physiol Lung Cell Mol
Physiol. 293:L753–L761. 2007.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Welihinda AA, Kaur M, Raveendran KS and
Amento EP: Enhancement of inosine-mediated A(2A)R signaling through
positive allosteric modulation. Cell Signal. 42:227–235.
2018.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Zhao N, Shao Z, Xia G, Liu H, Zhang L,
Zhao X, Dang S, Qian L, Xu W, Yu Z and Wang R: Protective role of
the CD73-A2AR axis in cirrhotic cardiomyopathy through negative
feedback regulation of the NF-κB pathway. Front Immunol.
15(1428551)2024.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Correale P, Caracciolo M, Bilotta F, Conte
M, Cuzzola M, Falcone C, Mangano C, Falzea AC, Iuliano E, Morabito
A, et al: Therapeutic effects of adenosine in high flow 21% oxygen
aereosol in patients with Covid19-pneumonia. PLoS One.
15(e0239692)2020.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Tozzi M and Novak I: Purinergic Receptors
in Adipose Tissue As Potential Targets in Metabolic Disorders.
Front Pharmacol. 8(878)2017.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Kotańska M, Dziubina A, Szafarz M, Mika K,
Bednarski M, Nicosia N, Temirak A, Müller CE and Kieć-Kononowicz K:
Preliminary Evidence of the Potent and Selective Adenosine A2B
Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its
Associated Metabolic Disorders in Mice. Int J Mol Sci.
23(13439)2022.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Zhao W, Ma L, Cai C and Gong X: Caffeine
Inhibits NLRP3 Inflammasome Activation by Suppressing MAPK/NF-κB
and A2aR Signaling in LPS-Induced THP-1 Macrophages. Int J Biol
Sci. 15:1571–1581. 2019.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Zohair B, Chraa D, Rezouki I, Benthami H,
Razzouki I, Elkarroumi M, Olive D, Karkouri M and Badou A: The
immune checkpoint adenosine 2A receptor is associated with
aggressive clinical outcomes and reflects an immunosuppressive
tumor microenvironment in human breast cancer. Front Immunol.
14(1201632)2023.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Leiva A, Guzmán-Gutiérrez E,
Contreras-Duarte S, Fuenzalida B, Cantin C, Carvajal L, Salsoso R,
Gutiérrez J, Pardo F and Sobrevia L: Adenosine receptors:
Modulators of lipid availability that are controlled by lipid
levels. Mol Aspects Med. 55:26–44. 2017.PubMed/NCBI View Article : Google Scholar
|
|
85
|
DeOliveira CC, Paiva Caria CR, Ferreira
Gotardo EM, Ribeiro ML and Gambero A: Role of A(1) and A(2A)
adenosine receptor agonists in adipose tissue inflammation induced
by obesity in mice. Eur J Pharmacol. 799:154–159. 2017.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Chen S, Fan J, Xie P, Ahn J, Fernandez M,
Billingham LK, Miska J, Wu JD, Wainwright DA, Fang D, et al: CD8+ T
cells sustain antitumor response by mediating crosstalk between
adenosine A2A receptor and glutathione/GPX4. J Clin Invest.
134(e170071)2024.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Bruzzese A, Dalton JAR and Giraldo J:
Insights into adenosine A2A receptor activation through cooperative
modulation of agonist and allosteric lipid interactions. PLoS
Comput Biol. 16(e1007818)2020.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Friedman B, Corciulo C, Castro CM and
Cronstein BN: Adenosine A2A receptor signaling promotes FoxO
associated autophagy in chondrocytes. Sci Rep.
11(968)2021.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Cai Y, Li H, Liu M, Pei Y, Zheng J, Zhou
J, Luo X, Huang W, Ma L, Yang Q, et al: Disruption of adenosine 2A
receptor exacerbates NAFLD through increasing inflammatory
responses and SREBP1c activity. Hepatology. 68:48–61.
2018.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Kong LR, Chen XH, Sun Q, Zhang KY, Xu L,
Ding L, Zhou YP, Zhang ZB, Lin JR and Gao PJ: Loss of C3a and C5a
receptors promotes adipocyte browning and attenuates diet-induced
obesity via activating inosine/A2aR pathway. Cell Rep.
42(112078)2023.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Lim J, Iyer A, Suen JY, Seow V, Reid RC,
Brown L and Fairlie DP: C5aR and C3aR antagonists each inhibit
diet-induced obesity, metabolic dysfunction, and adipocyte and
macrophage signaling. FASEB J. 27:822–831. 2013.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Kim K, Im H, Son Y, Kim M, Tripathi SK,
Jeong LS and Lee YH: Anti-obesity effects of the dual-active
adenosine A(2A)/A(3) receptor-ligand LJ-4378. Int J Obes (Lond).
46:2128–2136. 2022.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Shamsuzzaman A, Amin RS, Calvin AD,
Davison D and Somers VK: Severity of obstructive sleep apnea is
associated with elevated plasma fibrinogen in otherwise healthy
patients. Sleep Breath. 18:761–766. 2014.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Li H, Chen O, Ye Z, Zhang R, Hu H, Zhang
N, Huang J, Liu W and Sun X: Inhalation of high concentrations of
hydrogen ameliorates liver ischemia/reperfusion injury through
A(2A) receptor mediated PI3K-Akt pathway. Biochem Pharmacol.
130:83–92. 2017.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Huang X, Wu P, Huang F, Xu M, Chen M,
Huang K, Li GP, Xu M, Yao D and Wang L: Baicalin attenuates chronic
hypoxia-induced pulmonary hypertension via adenosine A(2A)
receptor-induced SDF-1/CXCR4/PI3K/AKT signaling. J Biomed Sci.
24(52)2017.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Dal-Cim T, Poluceno GG, Lanznaster D, de
Oliveira KA, Nedel CB and Tasca CI: Guanosine prevents oxidative
damage and glutamate uptake impairment induced by oxygen/glucose
deprivation in cortical astrocyte cultures: involvement of A(1) and
A(2A) adenosine receptors and PI3K, MEK, and PKC pathways.
Purinergic Signal. 15:465–476. 2019.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Wen MH, Wu MJ, Vinit S and Lee KZ:
Modulation of Serotonin and Adenosine 2A Receptors on Intermittent
Hypoxia-Induced Respiratory Recovery following Mid-Cervical
Contusion in the Rat. J Neurotrauma. 36:2991–3004. 2019.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Mathew OP: Apnea of prematurity:
Pathogenesis and management strategies. J Perinatol. 31:302–310.
2011.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Lv B, Yang L, Gao Y and Li G:
Epoxyeicosatrienoic Acids Attenuate LPS-Induced NIH/3T3 Cell
Fibrosis through the A(2A)R and PI3K/Akt Signaling Pathways. Bull
Exp Biol Med. 177:185–189. 2024.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Mori Y, Higuchi M, Masuyama N and Gotoh Y:
Adenosine A2A receptor facilitates calcium-dependent protein
secretion through the activation of protein kinase A and
phosphatidylinositol-3 kinase in PC12 cells. Cell Struct Funct.
29:101–110. 2004.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Vergadi E, Ieronymaki E, Lyroni K,
Vaporidi K and Tsatsanis C: Akt Signaling Pathway in Macrophage
Activation and M1/M2 Polarization. J Immunol. 198:1006–1014.
2017.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Troutman TD, Bazan JF and Pasare C:
Toll-like receptors, signaling adapters and regulation of the
pro-inflammatory response by PI3K. Cell Cycle. 11:3559–3567.
2012.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Li Q, Wang G, Xiong SH, Cao Y, Liu B, Sun
J, Li L, Mohammadtursun N, Yu H, Dong J and Wu J:
Bu-Shen-Fang-Chuan formula attenuates cigarette smoke-induced
inflammation by modulating the PI3K/Akt-Nrf2 and NF-κB signalling
pathways. J Ethnopharmacol. 261(113095)2020.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Li L, Qu Y, Mao M, Xiong Y and Mu D: The
involvement of phosphoinositid 3-kinase/Akt pathway in the
activation of hypoxia-inducible factor-1alpha in the developing rat
brain after hypoxia-ischemia. Brain Res. 1197:152–158.
2008.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Li L, Yin X, Ma N, Lin F, Kong X, Chi J
and Feng Z: Desferrioxamine regulates HIF-1 alpha expression in
neonatal rat brain after hypoxia-ischemia. Am J Transl Res.
6:377–383. 2014.PubMed/NCBI
|
|
106
|
Hutami IR, Izawa T, Khurel-Ochir T,
Sakamaki T, Iwasa A and Tanaka E: Macrophage Motility in Wound
Healing Is Regulated by HIF-1α via S1P Signaling. Int J Mol Sci.
22(8992)2021.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Cramer T, Yamanishi Y, Clausen BE, Förster
I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V,
et al: HIF-1alpha is essential for myeloid cell-mediated
inflammation. Cell. 112:645–657. 2003.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Peyssonnaux C, Datta V, Cramer T, Doedens
A, Theodorakis EA, Gallo RL, Hurtado-Ziola N, Nizet V and Johnson
RS: HIF-1alpha expression regulates the bactericidal capacity of
phagocytes. J Clin Invest. 115:1806–1815. 2005.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Kim SY, Jeong E, Joung SM and Lee JY:
PI3K/Akt contributes to increased expression of Toll-like receptor
4 in macrophages exposed to hypoxic stress. Biochem Biophys Res
Commun. 419:466–471. 2012.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Kunze R, Zhou W, Veltkamp R, Wielockx B,
Breier G and Marti HH: Neuron-specific prolyl-4-hydroxylase domain
2 knockout reduces brain injury after transient cerebral ischemia.
Stroke. 43:2748–2756. 2012.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Majmundar AJ, Wong WJ and Simon MC:
Hypoxia-inducible factors and the response to hypoxic stress. Mol
Cell. 40:294–309. 2010.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Vgontzas AN, Papanicolaou DA, Bixler EO,
Kales A, Tyson K and Chrousos GP: Elevation of plasma cytokines in
disorders of excessive daytime sleepiness: Role of sleep
disturbance and obesity. J Clin Endocrinol Metab. 82:1313–1316.
1997.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Ryan S: Adipose tissue inflammation by
intermittent hypoxia: Mechanistic link between obstructive sleep
apnoea and metabolic dysfunction. J Physiol. 595:2423–2430.
2017.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Toujani S, Kaabachi W, Mjid M, Hamzaoui K,
Cherif J and Beji M: Vitamin D deficiency and interleukin-17
relationship in severe obstructive sleep apnea-hypopnea syndrome.
Ann Thorac Med. 12:107–113. 2017.PubMed/NCBI View Article : Google Scholar
|
|
115
|
Gao C, Koko MYF, Ding M, Hong W, Li J,
Dong N and Hui M: Intestinal alkaline phosphatase (IAP, IAP
Enhancer) attenuates intestinal inflammation and alleviates insulin
resistance. Front Immunol. 13(927272)2022.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Xie Y, Shi X, Sheng K, Han G, Li W, Zhao
Q, Jiang B, Feng J, Li J and Gu Y: PI3K/Akt signaling transduction
pathway, erythropoiesis and glycolysis in hypoxia (Review). Mol Med
Rep. 19:783–791. 2019.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Rahman SMK, Uyama T, Hussain Z and Ueda N:
Roles of Endocannabinoids and Endocannabinoid-Like Molecules in
Energy Homeostasis and Metabolic Regulation: A Nutritional
Perspective. Annu Rev Nutr. 41:177–202. 2021.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Murillo-Rodríguez E: The Endocannabinoid
System as Prognostic Biomarker of the Obstructive Sleep Apnea
Morbidity in COVID-19-Recovered Individuals. Sleep Vigil.
5:205–211. 2021.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Wu YQ, Wang B, Song L, Wang Q, Chen XY and
Liu ZL: A study on the endogenous cannabinoid system synthetic and
catabolic enzyme levels in patients with obstructive sleep apnea.
Zhonghua Jie He He Hu Xi Za Zhi. 34:359–361. 2011.PubMed/NCBI(In Chinese).
|
|
120
|
Gonzaga CC, Gaddam KK, Ahmed MI, Pimenta
E, Thomas SJ, Harding SM, Oparil S, Cofield SS and Calhoun DA:
Severity of obstructive sleep apnea is related to aldosterone
status in subjects with resistant hypertension. J Clin Sleep Med.
6:363–368. 2010.PubMed/NCBI
|
|
121
|
Reiss AB, Carsons SE, Anwar K, Rao S,
Edelman SD, Zhang H, Fernandez P, Cronstein BN and Chan ES:
Atheroprotective effects of methotrexate on reverse cholesterol
transport proteins and foam cell transformation in human THP-1
monocyte/macrophages. Arthritis Rheum. 58:3675–3683.
2008.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Lee EJ, Heo W, Kim JY, Kim H, Kang MJ, Kim
BR, Kim JH, Park DY, Kim CH, Yoon JH and Cho HJ: Alteration of
inflammatory mediators in the upper and lower airways under chronic
intermittent hypoxia: Preliminary Animal Study. Mediators Inflamm.
2017(4327237)2017.PubMed/NCBI View Article : Google Scholar
|
|
123
|
Papandreou C: Independent associations
between fatty acids and sleep quality among obese patients with
obstructive sleep apnoea syndrome. J Sleep Res. 22:569–572.
2013.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Lebkuchen A, Carvalho VM, Venturini G,
Salgueiro JS, Freitas LS, Dellavance A, Martins FC, Lorenzi-Filho
G, Cardozo KHM and Drager LF: Metabolomic and lipidomic profile in
men with obstructive sleep apnoea: Implications for diagnosis and
biomarkers of cardiovascular risk. Sci Rep. 8(11270)2018.PubMed/NCBI View Article : Google Scholar
|
|
125
|
Xu H, Zheng X, Qian Y, Guan J, Yi H, Zou
J, Wang Y, Meng L, Zhao A, Yin S and Jia W: Metabolomics Profiling
for Obstructive Sleep Apnea and Simple Snorers. Sci Rep.
6(30958)2016.PubMed/NCBI View Article : Google Scholar
|
|
126
|
Kamphorst JJ, Cross JR, Fan J, de
Stanchina E, Mathew R, White EP, Thompson CB and Rabinowitz JD:
Hypoxic and Ras-transformed cells support growth by scavenging
unsaturated fatty acids from lysophospholipids. Proc Natl Acad Sci
USA. 110:8882–8887. 2013.PubMed/NCBI View Article : Google Scholar
|
|
127
|
Chen J, Chen J, Huang J, Li Z, Gong Y, Zou
B, Liu X, Ding L, Li P, Zhu Z, et al: HIF-2α upregulation mediated
by hypoxia promotes NAFLD-HCC progression by activating lipid
synthesis via the PI3K-AKT-mTOR pathway. Aging (Albany NY).
11:10839–10860. 2019.PubMed/NCBI View Article : Google Scholar
|
|
128
|
Ackerman D, Tumanov S, Qiu B,
Michalopoulou E, Spata M, Azzam A, Xie H, Simon MC and Kamphorst
JJ: Triglycerides Promote Lipid Homeostasis during Hypoxic Stress
by Balancing Fatty Acid Saturation. Cell Rep. 24:2596–2605.e5.
2018.PubMed/NCBI View Article : Google Scholar
|
|
129
|
Le TT, Berg NK, Harting MT, Li X,
Eltzschig HK and Yuan X: Purinergic Signaling in Pulmonary
Inflammation. Front Immunol. 10(1633)2019.PubMed/NCBI View Article : Google Scholar
|
|
130
|
Hanidziar D and Robson SC: Synapomorphic
features of hepatic and pulmonary vasculatures include comparable
purinergic signaling responses in host defense and modulation of
inflammation. Am J Physiol Gastrointest Liver Physiol.
321:G200–G212. 2021.PubMed/NCBI View Article : Google Scholar
|
|
131
|
Guieu R, Deharo JC, Maille B, Crotti L,
Torresani E, Brignole M and Parati G: Adenosine and the
Cardiovascular System: The Good and the Bad. J Clin Med.
9(1366)2020.PubMed/NCBI View Article : Google Scholar
|
|
132
|
Vecchio EA, White PJ and May LT: The
adenosine A(2B) G protein-coupled receptor: Recent advances and
therapeutic implications. Pharmacol Ther. 198:20–33.
2019.PubMed/NCBI View Article : Google Scholar
|
|
133
|
Bahreyni A, Avan A, Shabani M, Ryzhikov M,
Fiuji H, Soleimanpour S, Khazaei M and Hassanian SM: Therapeutic
potential of A2 adenosine receptor pharmacological regulators in
the treatment of cardiovascular diseases, recent progress, and
prospective. J Cell Physiol. 234:1295–1299. 2019.PubMed/NCBI View Article : Google Scholar
|
|
134
|
Sacramento JF, Gonzalez C, Gonzalez-Martin
MC and Conde SV: Adenosine Receptor Blockade by Caffeine Inhibits
Carotid Sinus Nerve Chemosensory Activity in Chronic Intermittent
Hypoxic Animals. Adv Exp Med Biol. 860:133–137. 2015.PubMed/NCBI View Article : Google Scholar
|
|
135
|
Conde SV, Monteiro EC and Sacramento JF:
Purines and Carotid Body: New Roles in Pathological Conditions.
Front Pharmacol. 8(913)2017.PubMed/NCBI View Article : Google Scholar
|
|
136
|
Li XC, Hong FF, Tu YJ, Li YA, Ma CY, Yu
CY, Fang L, Chen JY, Li ZL, Bao SJ, et al: Blockade of adenosine
A(2A) receptor alleviates cognitive dysfunction after chronic
exposure to intermittent hypoxia in mice. Exp Neurol.
350(113929)2022.PubMed/NCBI View Article : Google Scholar
|
|
137
|
Aranda JV and Beharry KD:
Pharmacokinetics, pharmacodynamics and metabolism of caffeine in
newborns. Semin Fetal Neonatal Med. 25(101183)2020.PubMed/NCBI View Article : Google Scholar
|
|
138
|
Kobayashi S and Millhorn DE: Stimulation
of expression for the adenosine A2A receptor gene by hypoxia in
PC12 cells. A potential role in cell protection. J Biol Chem.
274:20358–20365. 1999.PubMed/NCBI View Article : Google Scholar
|
|
139
|
Nadeem A, Fan M, Ansari HR, Ledent C and
Jamal Mustafa S: Enhanced airway reactivity and inflammation in A2A
adenosine receptor-deficient allergic mice. Am J Physiol Lung Cell
Mol Physiol. 292:L1335–L1344. 2007.PubMed/NCBI View Article : Google Scholar
|
|
140
|
Marshall NS, Yee BJ, Desai AV, Buchanan
PR, Wong KK, Crompton R, Melehan KL, Zack N, Rao SG, Gendreau RM,
et al: Two randomized placebo-controlled trials to evaluate the
efficacy and tolerability of mirtazapine for the treatment of
obstructive sleep apnea. Sleep. 31:824–831. 2008.PubMed/NCBI View Article : Google Scholar
|
|
141
|
Kent BD, Ryan S and McNicholas WT:
Obstructive sleep apnea and inflammation: relationship to
cardiovascular co-morbidity. Respir Physiol Neurobiol. 178:475–481.
2011.PubMed/NCBI View Article : Google Scholar
|
|
142
|
Peng L, Li Y, Li X, Du Y, Li L, Hu C,
Zhang J, Qin Y, Wei Y and Zhang H: Extracellular vesicles derived
from intermittent hypoxia-treated red blood cells impair
endothelial function through regulating eNOS phosphorylation and
ET-1 expression. Cardiovasc Drugs Ther. 35:901–913. 2021.PubMed/NCBI View Article : Google Scholar
|
|
143
|
Lv R, Liu X, Zhang Y, Dong N, Wang X, He
Y, Yue H and Yin Q: Pathophysiological mechanisms and therapeutic
approaches in obstructive sleep apnea syndrome. Signal Transduct
Target Ther. 8(218)2023.PubMed/NCBI View Article : Google Scholar
|
|
144
|
Popadic V, Brajkovic M, Klasnja S, Milic
N, Rajovic N, Lisulov DP, Divac A, Ivankovic T, Manojlovic A,
Nikolic N, et al: Correlation of dyslipidemia and inflammation with
obstructive sleep apnea severity. Front Pharmacol.
13(897279)2022.PubMed/NCBI View Article : Google Scholar
|
|
145
|
Sun X, Wang C, He Y, Chen K and Miao Y:
Effect of inflammatory cytokines and plasma metabolome on OSA: A
bidirectional two-sample Mendelian randomization study and
mediation analysis. Front Immunol. 15(1416870)2024.PubMed/NCBI View Article : Google Scholar
|
|
146
|
Andrade RGS, Viana FM, Nascimento JA,
Drager LF, Moffa A, Brunoni AR, Genta PR and Lorenzi-Filho G: Nasal
vs Oronasal CPAP for OSA Treatment: A Meta-Analysis. Chest.
153:665–674. 2018.PubMed/NCBI View Article : Google Scholar
|
|
147
|
Shen C, Ou Y, Ouyang R and Zong D:
Prevalence and characteristics of pain in moderate-to-severe
obstructive sleep apnea patients and effect of CPAP treatment. Sci
Rep. 13(15758)2023.PubMed/NCBI View Article : Google Scholar
|
|
148
|
Lorenzi-Filho G, Almeida FR and Strollo
PJ: Treating OSA: Current and emerging therapies beyond CPAP.
Respirology. 22:1500–1507. 2017.PubMed/NCBI View Article : Google Scholar
|
|
149
|
Chang JL, Goldberg AN, Alt JA, Mohammed A,
Ashbrook L, Auckley D, Ayappa I, Bakhtiar H, Barrera JE, Bartley
BL, et al: International Consensus Statement on Obstructive Sleep
Apnea. Int Forum Allergy Rhinol. 13:1061–1482. 2023.PubMed/NCBI View Article : Google Scholar
|
|
150
|
MacKay S, Carney AS, Catcheside PG,
Chai-Coetzer CL, Chia M, Cistulli PA, Hodge JC, Jones A, Kaambwa B,
Lewis R, et al: Effect of multilevel upper airway surgery vs
medical management on the apnea-hypopnea index and patient-reported
daytime sleepiness among patients with moderate or severe
obstructive sleep apnea: The SAMS Randomized Clinical Trial. JAMA.
324:1168–1179. 2020.PubMed/NCBI View Article : Google Scholar
|
|
151
|
Sánchez AI, Martínez P, Miró E, Bardwell
WA and Buela-Casal G: CPAP and behavioral therapies in patients
with obstructive sleep apnea: Effects on daytime sleepiness, mood,
and cognitive function. Sleep Med Rev. 13:223–233. 2009.PubMed/NCBI View Article : Google Scholar
|
|
152
|
Schmickl CN, Landry SA, Orr JE, Chin K,
Murase K, Verbraecken J, Javaheri S, Edwards BA, Owens RL and
Malhotra A: Acetazolamide for OSA and Central Sleep Apnea: A
Comprehensive Systematic Review and Meta-Analysis. Chest.
158:2632–2645. 2020.PubMed/NCBI View Article : Google Scholar
|
|
153
|
Ulrich S, Nussbaumer-Ochsner Y, Vasic I,
Hasler E, Latshang TD, Kohler M, Muehlemann T, Wolf M and Bloch KE:
Cerebral oxygenation in patients with OSA: effects of hypoxia at
altitude and impact of acetazolamide. Chest. 146:299–308.
2014.PubMed/NCBI View Article : Google Scholar
|
|
154
|
Chapman JL, Vakulin A, Hedner J, Yee BJ
and Marshall NS: Modafinil/armodafinil in obstructive sleep apnoea:
A systematic review and meta-analysis. Eur Respir J. 47:1420–1428.
2016.PubMed/NCBI View Article : Google Scholar
|
|
155
|
Mashaqi S, Patel SI, Combs D, Estep L,
Helmick S, Machamer J and Parthasarathy S: The hypoglossal nerve
stimulation as a novel therapy for treating obstructive sleep
apnea-a literature review. Int J Environ Res Public Health.
18(1642)2021.PubMed/NCBI View Article : Google Scholar
|
|
156
|
Akinnusi ME, Laporta R and El-Solh AA:
Lectin-like oxidized low-density lipoprotein receptor-1 modulates
endothelial apoptosis in obstructive sleep apnea. Chest.
140:1503–1510. 2011.PubMed/NCBI View Article : Google Scholar
|
|
157
|
Feres MC, Fonseca FA, Cintra FD,
Mello-Fujita L, de Souza AL, De Martino MC, Tufik S and Poyares D:
An assessment of oxidized LDL in the lipid profiles of patients
with obstructive sleep apnea and its association with both
hypertension and dyslipidemia, and the impact of treatment with
CPAP. Atherosclerosis. 241:342–349. 2015.PubMed/NCBI View Article : Google Scholar
|
|
158
|
Trevethick MA, Mantell SJ, Stuart EF,
Barnard A, Wright KN and Yeadon M: Treating lung inflammation with
agonists of the adenosine A2A receptor: Promises, problems and
potential solutions. Br J Pharmacol. 155:463–474. 2008.PubMed/NCBI View Article : Google Scholar
|
|
159
|
Guo D, Mulder-Krieger T, IJzerman AP and
Heitman LH: Functional efficacy of adenosine A2A
receptor agonists is positively correlated to their receptor
residence time. Br J Pharmacol. 166:1846–1859. 2012.PubMed/NCBI View Article : Google Scholar
|
|
160
|
de Lera Ruiz M, Lim YH and Zheng J:
Adenosine A2A receptor as a drug discovery target. J Med Chem.
57:3623–3650. 2014.PubMed/NCBI View Article : Google Scholar
|
|
161
|
Al-Attraqchi OHA, Attimarad M, Venugopala
KN, Nair A and Al-Attraqchi NHA: Adenosine A2A receptor as a
potential drug target-current status and future perspectives. Curr
Pharm Des. 25:2716–2740. 2019.PubMed/NCBI View Article : Google Scholar
|
|
162
|
Kohler M and Stradling JR: Mechanisms of
vascular damage in obstructive sleep apnea. Nat Rev Cardiol.
7:677–685. 2010.PubMed/NCBI View Article : Google Scholar
|
|
163
|
Gambino F, Zammuto MM, Virzì A, Conti G
and Bonsignore MR: Treatment options in obstructive sleep apnea.
Intern Emerg Med. 17:971–978. 2022.PubMed/NCBI View Article : Google Scholar
|
